• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用同基因细胞进行的全基因组CRISPR筛选揭示了肿瘤抑制因子缺失所赋予的脆弱性。

Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors.

作者信息

Feng Xu, Tang Mengfan, Dede Merve, Su Dan, Pei Guangsheng, Jiang Dadi, Wang Chao, Chen Zhen, Li Mi, Nie Litong, Xiong Yun, Li Siting, Park Jeong-Min, Zhang Huimin, Huang Min, Szymonowicz Klaudia, Zhao Zhongming, Hart Traver, Chen Junjie

机构信息

Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

Sci Adv. 2022 May 13;8(19):eabm6638. doi: 10.1126/sciadv.abm6638.

DOI:10.1126/sciadv.abm6638
PMID:35559673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9106303/
Abstract

Exploiting cancer vulnerabilities is critical for the discovery of anticancer drugs. However, tumor suppressors cannot be directly targeted because of their loss of function. To uncover specific vulnerabilities for cells with deficiency in any given tumor suppressor(s), we performed genome-scale CRISPR loss-of-function screens using a panel of isogenic knockout cells we generated for 12 common tumor suppressors. Here, we provide a comprehensive and comparative dataset for genetic interactions between the whole-genome protein-coding genes and a panel of tumor suppressor genes, which allows us to uncover known and new high-confidence synthetic lethal interactions. Mining this dataset, we uncover essential paralog gene pairs, which could be a common mechanism for interpreting synthetic lethality. Moreover, we propose that some tumor suppressors could be targeted to suppress proliferation of cells with deficiency in other tumor suppressors. This dataset provides valuable information that can be further exploited for targeted cancer therapy.

摘要

利用癌症脆弱性对于抗癌药物的发现至关重要。然而,由于肿瘤抑制因子功能丧失,无法直接将其作为靶点。为了揭示任何给定肿瘤抑制因子缺陷细胞的特定脆弱性,我们使用为12种常见肿瘤抑制因子生成的一组同基因敲除细胞进行了全基因组CRISPR功能丧失筛选。在此,我们提供了一个关于全基因组蛋白质编码基因与一组肿瘤抑制基因之间遗传相互作用的全面且具有可比性的数据集,这使我们能够揭示已知和新的高可信度合成致死相互作用。通过挖掘该数据集,我们发现了必需的旁系同源基因对,这可能是解释合成致死性的一种常见机制。此外,我们提出某些肿瘤抑制因子可作为靶点来抑制其他肿瘤抑制因子缺陷细胞的增殖。该数据集提供了有价值的信息,可进一步用于靶向癌症治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ec/9106303/829796172448/sciadv.abm6638-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ec/9106303/9656ce5f4418/sciadv.abm6638-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ec/9106303/0d345ecf44ad/sciadv.abm6638-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ec/9106303/db5668608d1d/sciadv.abm6638-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ec/9106303/8d9b7069e4e3/sciadv.abm6638-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ec/9106303/e83a79f72643/sciadv.abm6638-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ec/9106303/829796172448/sciadv.abm6638-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ec/9106303/9656ce5f4418/sciadv.abm6638-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ec/9106303/0d345ecf44ad/sciadv.abm6638-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ec/9106303/db5668608d1d/sciadv.abm6638-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ec/9106303/8d9b7069e4e3/sciadv.abm6638-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ec/9106303/e83a79f72643/sciadv.abm6638-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ec/9106303/829796172448/sciadv.abm6638-f6.jpg

相似文献

1
Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors.使用同基因细胞进行的全基因组CRISPR筛选揭示了肿瘤抑制因子缺失所赋予的脆弱性。
Sci Adv. 2022 May 13;8(19):eabm6638. doi: 10.1126/sciadv.abm6638.
2
Discovery of synthetic lethal and tumor suppressor paralog pairs in the human genome.在人类基因组中发现合成致死和肿瘤抑制基因的平行基因对。
Cell Rep. 2021 Aug 31;36(9):109597. doi: 10.1016/j.celrep.2021.109597.
3
CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions.CRISPR 筛选提供了对癌症易损性的全面评估,但对高度扩增的基因组区域产生了假阳性结果。
Cancer Discov. 2016 Aug;6(8):900-13. doi: 10.1158/2159-8290.CD-16-0178. Epub 2016 Jun 3.
4
A CRISPR Platform for Targeted In Vivo Screens.用于体内靶向筛选的CRISPR平台。
Methods Mol Biol. 2023;2614:397-409. doi: 10.1007/978-1-0716-2914-7_24.
5
Identifying chemogenetic interactions from CRISPR screens with drugZ.利用 drugZ 从 CRISPR 筛选中鉴定化学生物遗传学相互作用。
Genome Med. 2019 Aug 22;11(1):52. doi: 10.1186/s13073-019-0665-3.
6
Multiple-gene targeting and mismatch tolerance can confound analysis of genome-wide pooled CRISPR screens.多基因靶向和错配容忍可能会混淆全基因组池 CRISPR 筛选分析。
Genome Biol. 2019 Jan 25;20(1):21. doi: 10.1186/s13059-019-1621-7.
7
Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy.无偏倚 CRISPR/Cas9 筛选鉴定的关键癌症脆弱性可为高效癌症免疫治疗提供信息。
Eur J Immunol. 2020 Dec;50(12):1871-1884. doi: 10.1002/eji.202048712. Epub 2020 Dec 1.
8
Choosing CRISPR-based screens in cancer.在癌症中选择基于CRISPR的筛选方法。
Nat Methods. 2017 Mar 31;14(4):343-346. doi: 10.1038/nmeth.4232.
9
Comprehensive prediction of robust synthetic lethality between paralog pairs in cancer cell lines.全面预测癌细胞系中直系同源基因对之间的稳健合成致死性。
Cell Syst. 2021 Dec 15;12(12):1144-1159.e6. doi: 10.1016/j.cels.2021.08.006. Epub 2021 Sep 15.
10
Mapping a functional cancer genome atlas of tumor suppressors in mouse liver using AAV-CRISPR-mediated direct in vivo screening.利用 AAV-CRISPR 介导的直接体内筛选技术绘制小鼠肝脏肿瘤抑制因子的功能癌症基因组图谱。
Sci Adv. 2018 Feb 28;4(2):eaao5508. doi: 10.1126/sciadv.aao5508. eCollection 2018 Feb.

引用本文的文献

1
Synthetic Lethality-Based Targets and Their Exploration in Tumour Combination Strategies.基于合成致死性的靶点及其在肿瘤联合治疗策略中的探索
J Cell Mol Med. 2025 Aug;29(16):e70756. doi: 10.1111/jcmm.70756.
2
Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancers.胞苷二磷酸二酰甘油合酶2是间充质样癌症中的一个合成致死靶点。
Nat Genet. 2025 Jul 4. doi: 10.1038/s41588-025-02221-2.
3
Proteomic Analysis of ARID1A-Deficient Ovarian Clear Cell Carcinoma Cells Reveals Differential Mitochondria ETC Subunit Abundances and Targetable Mitochondrial Pathways.

本文引用的文献

1
Discovery of putative tumor suppressors from CRISPR screens reveals rewired lipid metabolism in acute myeloid leukemia cells.从 CRISPR 筛选中发现潜在的肿瘤抑制因子揭示了急性髓系白血病细胞中重新布线的脂质代谢。
Nat Commun. 2021 Nov 11;12(1):6506. doi: 10.1038/s41467-021-26867-8.
2
Combinatorial CRISPR screen identifies fitness effects of gene paralogues.组合型 CRISPR 筛选鉴定基因旁系同源物的适应度效应。
Nat Commun. 2021 Feb 26;12(1):1302. doi: 10.1038/s41467-021-21478-9.
3
Improved analysis of CRISPR fitness screens and reduced off-target effects with the BAGEL2 gene essentiality classifier.
ARID1A缺陷型卵巢透明细胞癌细胞的蛋白质组学分析揭示了线粒体电子传递链亚基丰度的差异以及可靶向的线粒体途径。
Int J Mol Sci. 2025 Jun 7;26(12):5466. doi: 10.3390/ijms26125466.
4
Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶(Mpro)的靶向蛋白降解剂比单独的酶抑制更具活性,且对奈玛特韦耐药病毒具有活性。
Commun Med (Lond). 2025 Apr 26;5(1):140. doi: 10.1038/s43856-025-00863-1.
5
Synthetic lethality in cancer: a protocol for scoping review of gene interactions from synthetic lethal screens and functional studies.癌症中的合成致死性:一项关于对来自合成致死筛选和功能研究的基因相互作用进行范围综述的方案
Syst Rev. 2025 Apr 8;14(1):81. doi: 10.1186/s13643-025-02814-2.
6
PRODE recovers essential and context-essential genes through neighborhood-informed scores.PRODE通过邻域信息分数恢复必需基因和上下文必需基因。
Genome Biol. 2025 Feb 28;26(1):42. doi: 10.1186/s13059-025-03501-0.
7
Co-essentiality analysis identifies PRR12 as a cohesin interacting protein and contributor to genomic integrity.共必需性分析确定PRR12为一种与黏连蛋白相互作用的蛋白质,并对基因组完整性有贡献。
Dev Cell. 2025 Apr 21;60(8):1217-1233.e7. doi: 10.1016/j.devcel.2024.12.015. Epub 2024 Dec 31.
8
Mapping quantitative trait loci regions associated with Marek's disease on chicken autosomes by means of selective DNA pooling.利用选择性DNA池定位鸡常染色体上与马立克氏病相关的数量性状基因座区域。
Sci Rep. 2024 Dec 30;14(1):31896. doi: 10.1038/s41598-024-83356-w.
9
Genome-Wide CRISPR Screen Identifies KEAP1 Perturbation as a Vulnerability of ARID1A-Deficient Cells.全基因组CRISPR筛选确定KEAP1扰动是ARID1A缺陷细胞的一个脆弱点。
Cancers (Basel). 2024 Aug 24;16(17):2949. doi: 10.3390/cancers16172949.
10
Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers.KL-50,一种用于治疗耐药性脑癌的咪唑并四嗪候选药物的作用机制。
J Am Chem Soc. 2024 Jul 10;146(27):18241-18252. doi: 10.1021/jacs.3c06483. Epub 2024 May 30.
通过 BAGEL2 基因必需性分类器提高 CRISPR 适应性筛选分析和降低脱靶效应。
Genome Med. 2021 Jan 6;13(1):2. doi: 10.1186/s13073-020-00809-3.
4
Multiplex enCas12a screens detect functional buffering among paralogs otherwise masked in monogenic Cas9 knockout screens.多重iplex Cas12a 筛选检测到在单基因 Cas9 敲除筛选中被掩盖的旁系同源物之间的功能缓冲。
Genome Biol. 2020 Oct 15;21(1):262. doi: 10.1186/s13059-020-02173-2.
5
ATR inhibition potentiates ionizing radiation-induced interferon response via cytosolic nucleic acid-sensing pathways.ATR 抑制通过细胞质核酸感应途径增强电离辐射诱导的干扰素反应。
EMBO J. 2020 Jul 15;39(14):e104036. doi: 10.15252/embj.2019104036. Epub 2020 Jun 2.
6
The SWI/SNF complex in cancer - biology, biomarkers and therapy.SWI/SNF 复合物在癌症中的作用——生物学、生物标志物和治疗。
Nat Rev Clin Oncol. 2020 Jul;17(7):435-448. doi: 10.1038/s41571-020-0357-3. Epub 2020 Apr 17.
7
Genome-wide CRISPR screen uncovers a synergistic effect of combining Haspin and Aurora kinase B inhibition.全基因组 CRISPR 筛选揭示了 Haspin 和 Aurora 激酶 B 抑制联合使用的协同效应。
Oncogene. 2020 May;39(21):4312-4322. doi: 10.1038/s41388-020-1296-2. Epub 2020 Apr 16.
8
Genetic determinants of cellular addiction to DNA polymerase theta.DNA 聚合酶 θ 细胞成瘾的遗传决定因素。
Nat Commun. 2019 Sep 19;10(1):4286. doi: 10.1038/s41467-019-12234-1.
9
Identifying chemogenetic interactions from CRISPR screens with drugZ.利用 drugZ 从 CRISPR 筛选中鉴定化学生物遗传学相互作用。
Genome Med. 2019 Aug 22;11(1):52. doi: 10.1186/s13073-019-0665-3.
10
WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs.WebGestalt 2019:基因集分析工具包,具有全新的用户界面和 API。
Nucleic Acids Res. 2019 Jul 2;47(W1):W199-W205. doi: 10.1093/nar/gkz401.